<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05113121</url>
  </required_header>
  <id_info>
    <org_study_id>PEXPUPIL</org_study_id>
    <nct_id>NCT05113121</nct_id>
  </id_info>
  <brief_title>Correlation Between Pupil Size and Ocular Signs of Pseudoexfoliation Syndrome</brief_title>
  <official_title>Correlation Between Pupil Size and Ocular Signs in Pseudoexfoliation Syndrome (PEX): a Contralateral Eye Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study possible correlation between the size of the pupil in both room light and after&#xD;
      dilation between both eyes in bilateral pseudoexfoliation with Intraocular pressure, lens&#xD;
      clarity and stability, Optic disc , Visual changes and glaucoma changes by optical coherence&#xD;
      tomography&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For each patient. Full preoperative ophthalmological assessment will be done using slit lamp&#xD;
      , size of the pupil in regular room light (usually around 2000 Lux) and post dilation with&#xD;
      tropicamide 1%. baseline IOP measurement using Goldmann applanation tonometer, UCDVA&#xD;
      (Uncorrected Distance Visual Acuity)and CDVA (Corrected Distance visual acuity), lens&#xD;
      opacification or clarity, stability or subluxation. corneal endothelial cell count. Fundus&#xD;
      examination using 90 D or 78D lenses, Humphrey visual field (24-2) analysis and optical&#xD;
      coherence tomography on retinal nerve fiber layer (RNFL) and ganglion cell complex.(GCC)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>correlation between pupil size and severity of Pseudoexfoliation</measure>
    <time_frame>2-3 months</time_frame>
    <description>in each eye of the same patient we study correlation between pupil size with ntraocular pressure, lens status, corneal endothelial count and glaucomatous damage represented by (optic disc changes (cup to disc ratio) and OCT changes (RNFL and GCC)</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pseudoexfoliation Syndrome</condition>
  <condition>Pseudoexfoliation Glaucoma in Both Eyes</condition>
  <condition>Pseudoexfoliation of Lens; Glaucoma</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>, Humphrey visual field (24-2) analysis and optical coherence tomography on retinal nerve fiber layer (RNFL) and ganglion cell complex.(GCC)</intervention_name>
    <description>, Humphrey visual field (24-2) analysis and optical coherence tomography on retinal nerve fiber layer (RNFL) and ganglion cell complex.(GCC)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients , age : 18 years and older&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All patients with pseudoexfoliation syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        previous ocular surgery or ocular trauma affecting pupil. Any systemic or neurologic&#xD;
        disease affecting pupil&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Rateb</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud Rateb, MD</last_name>
    <phone>+201008348480</phone>
    <email>rateb@aun.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Shazly TA, Farrag AN, Kamel A, Al-Hussaini AK. Prevalence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Upper Egypt. BMC Ophthalmol. 2011 Jun 27;11:18. doi: 10.1186/1471-2415-11-18.</citation>
    <PMID>21707986</PMID>
  </reference>
  <reference>
    <citation>Plateroti P, Plateroti AM, Abdolrahimzadeh S, Scuderi G. Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma: A Review of the Literature with Updates on Surgical Management. J Ophthalmol. 2015;2015:370371. doi: 10.1155/2015/370371. Epub 2015 Oct 29. Review.</citation>
    <PMID>26605078</PMID>
  </reference>
  <reference>
    <citation>Tekin K, Kiziltoprak H, Sekeroglu MA, Yetkin E, Bayraktar S, Yilmazbas P. Static and dynamic pupil characteristics in pseudoexfoliation syndrome and glaucoma. Clin Exp Optom. 2020 May;103(3):332-338. doi: 10.1111/cxo.12945. Epub 2019 Jul 30.</citation>
    <PMID>31364197</PMID>
  </reference>
  <reference>
    <citation>Akman A, Yilmaz G, Oto S, Akova YA. Comparison of various pupil dilatation methods for phacoemulsification in eyes with a small pupil secondary to pseudoexfoliation. Ophthalmology. 2004 Sep;111(9):1693-8.</citation>
    <PMID>15350324</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 28, 2021</study_first_submitted>
  <study_first_submitted_qc>October 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mahmoud F. Rateb</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>cataract</keyword>
  <keyword>glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Exfoliation Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD can be shared upon request after completion of the research</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>after completion of data and for five years.</ipd_time_frame>
    <ipd_access_criteria>It will be upon request through email</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

